Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 188-0551 Spray in Plaque Psoriasis
NCT03731052Phase 3Completed
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 188-0551 in plaque psoriasis. Started Oct 2018; status: completed.
02
Drugs
188-0551
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03731052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731052.